InsidersTradesSigma
Discover the detailed record of transactions filed by Gaspar Bobby, Chief Executive Officer. Insider active across 1 companies, notably Orchard Therapeutics plc. Aggregated, 1 disclosures have been logged. Total volume traded: €10k. The latest transaction was disclosed on 1 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Bobby Gaspar is the Chief Executive Officer of Orchard Therapeutics plc, a biopharmaceutical company. He leads the company's operations and strategy, focusing on the development of innovative therapies. His expertise in the biopharmaceutical sector is essential for the company's growth.